Drug
Voriconazole Inhalation Powder
Voriconazole Inhalation Powder is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
2
67%
Phase Distribution
2
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 1Safety & dosage
2(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 12 (100.0%)
Trials by Status
completed267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
unknown
Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis
NCT05897294
completedphase_1
Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma
NCT04576325
completedphase_1
Single Ascending Dose and Multiple Ascending Dose Study of Voriconazole Inhalation Powder in Healthy Adult Subjects
NCT04872231
Clinical Trials (3)
Showing 3 of 3 trials
NCT05897294
Voriconazole Inhalation Powder for the Treatment of Pulmonary Aspergillosis
NCT04576325Phase 1
Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma
NCT04872231Phase 1
Single Ascending Dose and Multiple Ascending Dose Study of Voriconazole Inhalation Powder in Healthy Adult Subjects
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3